Multiple myeloma starts in the plasma cells inside your bone marrow. People with multiple myeloma have high levels of certain proteins in their blood and urine. An oncologist (a medical doctor ...

Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that the FDA has granted orphan drug designation (ODD) to ...

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.

The hallmark characteristic of having high levels of M protein in the blood, noted in people with multiple myeloma, can cause: Tumors Kidney damage Bone destruction Impaired immune function Multiple ...

In this video, Sham Mailankody, MBBS discusses the current state of the pipeline for developing multiple myeloma treatments.

Researchers sought to identify prognostic factors for survival in patients with newly diagnosed multiple myeloma.

leading to the overproduction of abnormal proteins that can cause damage to bones, kidneys, and the immune system. 2 Today, treatment for multiple myeloma often involves an intensive combination ...

Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...

Multiple myeloma (MM) is a B-cell malignancy characterized by an accumulation of neoplastic plasma cells that usually secrete monoclonal proteins. Recent studies have shown that most, if not all ...